Search
for
Sort by
Research 811–840 of 1000+
- Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis
- Hormonal acne: leading to a paradigm shift in the management of acne
- Why are men with premature alopecia at higher risk of benign prostatic hyperplasia? And what about prostate cancer?
- Mind the hair
- Effect of Prunus Tomentosa Thumb Total Flavone on hair growth
- Patentability of dosage regime invention in the form of Swiss-type claim under Chinese patent law
- Editor bids adieu
- A focus on important reproductive health care issues – cancer, urinary incontinence and the consequences of pre‐term birth
- Dermatological manifestations associated with pregnancy
- Avoiding pitfalls in planning a hair transplant
- Regenerative Biology and Medicine
- Quality of life in patients with seborrheic dermatitis
- Regulation and Implementation of Pharmaceutical and Other Regulations
- Australasian Society for Dermatology Research Meeting, May 2006
- UK High Court Revokes Escitalopram UK Patent; Validity of Second Medical use Claims Based on Dosage Regimes in the UK; Stay of Proceedings in the UK Courts Pending EPO Opposition Proceedings
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Syndromes of Severe Insulin Resistance (SSIRs)
- NEW PROPRIETARY BRANDS: Gabapentin
- NEW PROPRIETARY BRANDS: Cephalexin
- New drugs: Agalsidase beta
- NEW FORMULATIONS: Sodium cromoglycate
- NEW FORMULATIONS: Glatiramer acetate
- Announcements
- 086 Evaluation of hair re-growth by cyclosporine and minoxidil using C3H mouse model
- Studies of the modulation of MHC antigen and cell adhesion molecule expression on human dermal papilla cells
- 1994 Forthcoming educational events
- Worldwide review of restrictions placed upon people with HIV/AIDS
- Patent Evaluation: Δ-4,6-Steroids as Potent 5α-Reductase Inhibitors
- Interest of a vitamin and mineral supplement in the management of telogen effluvium: Clinical study on Brazilian women
- Histopathologic prognostic factors for alopecia areata treated by intralesional corticosteroid